Agilent Technologies Inc.
ANYSECIK 1090872Healthcare / Diagnostics & Researchfiscal year ends October66 quarters since 2010
Latest quarter Q3 FY2026, filed September 1, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of September 1, 2026.
Net income losses drawn in red.
Operating cash flow less capital expenditures; negative quarters in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed September 1, 2026.
| Millions of dollars | Q3 FY2026ended Jul 31, 2026filed Sep 1, 2026 | Q2 FY2026ended Apr 30, 2026filed Jun 1, 2026 | Q1 FY2026ended Jan 31, 2026filed Mar 3, 2026 | Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025 | Q3 FY2025ended Jul 31, 2025filed Aug 29, 2025 | Q2 FY2025ended Apr 30, 2025filed Jun 2, 2025 | Q1 FY2025ended Jan 31, 2025filed Mar 3, 2025 | Q4 FY2024ended Oct 31, 2024filed Dec 20, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,878 | 1,835 | 1,798 | 1,861 | 1,738 | 1,668 | 1,681 | 1,701 | +8.1% |
| Cost of revenue | 836 | 845 | 852 | 871 | 850 | 802 | 782 | 785 | −1.6% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | 123 | 126 | 117 | 119 | 111 | 112 | 113 | 111 | +10.8% |
| Selling, general and administrative | 475 | 465 | 476 | 428 | 417 | 454 | 410 | 397 | +13.9% |
| Operating income | 444 | 399 | 353 | 443 | 360 | 300 | 376 | 408 | +23.3% |
| Other income (expense) | 14 | 21 | 21 | 9 | 18 | (25) | 4 | 1 | −22.2% |
| Pretax income | 444 | 408 | 364 | 442 | 366 | 260 | 367 | 401 | +21.3% |
| Income tax | 82 | 69 | 59 | 8 | 30 | 45 | 49 | 50 | +173.3% |
| Net income | 362 | 339 | 305 | 434 | 336 | 215 | 318 | 351 | +7.7% |
| Diluted EPS ($) | 1.28 | 1.20 | 1.07 | — | 1.18 | 0.75 | 1.11 | — | +8.5% |
| Diluted shares (millions) | 283 | 283 | 284 | — | 285 | 285 | 287 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed September 1, 2026.
| Millions of dollars | Q3 FY2026ended Jul 31, 2026filed Sep 1, 2026 | Q2 FY2026ended Apr 30, 2026filed Jun 1, 2026 | Q1 FY2026ended Jan 31, 2026filed Mar 3, 2026 | Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025 | Q3 FY2025ended Jul 31, 2025filed Aug 29, 2025 | Q2 FY2025ended Apr 30, 2025filed Jun 2, 2025 | Q1 FY2025ended Jan 31, 2025filed Mar 3, 2025 | Q4 FY2024ended Oct 31, 2024filed Dec 20, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,758 | 1,807 | 1,758 | 1,789 | 1,535 | 1,486 | 1,467 | 1,329 | +14.5% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | 4,693 | 4,763 | 4,615 | 4,594 | 4,253 | 4,208 | 4,107 | 3,959 | +10.3% |
| Total assets | 13,967 | 13,065 | 12,813 | 12,727 | 12,226 | 12,158 | 11,914 | 11,846 | +14.2% |
| Total current liabilities | 2,289 | 2,269 | 2,234 | 2,347 | 1,892 | 2,012 | 1,869 | 1,895 | +21.0% |
| Long-term debt | 3,645 | 3,051 | 3,050 | 3,050 | 3,350 | 3,349 | 3,347 | 3,345 | +8.8% |
| Total liabilities | 6,604 | 5,943 | 5,905 | 5,986 | 5,856 | 6,022 | 5,887 | 5,948 | +12.8% |
| Stockholders’ equity | 7,363 | 7,122 | 6,908 | 6,741 | 6,370 | 6,136 | 6,027 | 5,898 | +15.6% |
| Shares outstanding (millions) | 282 | 282 | 283 | 283 | 284 | 284 | 285 | 286 | — |
Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed September 1, 2026.
| Millions of dollars | Q3 FY2026ended Jul 31, 2026filed Sep 1, 2026 | Q2 FY2026ended Apr 30, 2026filed Jun 1, 2026 | Q1 FY2026ended Jan 31, 2026filed Mar 3, 2026 | Q4 FY2025ended Oct 31, 2025filed Dec 22, 2025 | Q3 FY2025ended Jul 31, 2025filed Aug 29, 2025 | Q2 FY2025ended Apr 30, 2025filed Jun 2, 2025 | Q1 FY2025ended Jan 31, 2025filed Mar 3, 2025 | Q4 FY2024ended Oct 31, 2024filed Dec 20, 2024 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 519 | 277 | 268 | 545 | 362 | 221 | 431 | 481 | +43.4% |
| Capital expenditures | 80 | 76 | 93 | 93 | 103 | 114 | 97 | 93 | −22.3% |
| Free cash flow (CFO − capex) | 439 | 201 | 175 | 452 | 259 | 107 | 334 | 388 | +69.5% |
| Depreciation and amortization | 66 | 67 | 67 | 71 | 72 | 73 | 72 | 69 | −8.3% |
| Share repurchases | 78 | 65 | 152 | 85 | 85 | 165 | 90 | 335 | −8.2% |
| Dividends paid | 72 | 72 | 72 | 70 | 71 | 70 | 71 | 68 | +1.4% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed December 22, 2025.
Income statement
| Millions of dollars | FY2025ended Oct 31, 2025filed Dec 22, 2025 | FY2024ended Oct 31, 2024filed Dec 20, 2024 | FY2023ended Oct 31, 2023filed Dec 20, 2023 | FY2022ended Oct 31, 2022filed Dec 21, 2022 | FY2021ended Oct 31, 2021filed Dec 17, 2021 | FY2020ended Oct 31, 2020filed Dec 18, 2020 | FY2019ended Oct 31, 2019filed Dec 19, 2019 | FY2018ended Oct 31, 2018filed Dec 20, 2018 | FY2017ended Oct 31, 2017filed Dec 21, 2017 | FY2016ended Oct 31, 2016filed Dec 20, 2016 | FY2015ended Oct 31, 2015filed Dec 21, 2015 | FY2014ended Oct 31, 2014filed Dec 22, 2014 | FY2013ended Oct 31, 2013filed Dec 19, 2013 | FY2012ended Oct 31, 2012filed Dec 20, 2012 | FY2011ended Oct 31, 2011filed Dec 16, 2011 | FY2010ended Oct 31, 2010filed Dec 20, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 6,948 | 6,510 | 6,833 | 6,848 | 6,319 | 5,339 | 5,163 | 4,914 | 4,472 | 4,202 | 4,038 | 4,048 | 3,894 | 6,858 | 6,615 | 5,444 |
| Cost of revenue | 3,305 | 2,975 | 3,368 | 3,126 | 2,912 | 2,502 | 2,358 | 2,234 | 2,073 | 2,005 | 1,997 | 2,072 | 1,987 | 3,254 | 3,086 | 2,514 |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | 455 | 479 | 481 | 467 | 441 | 495 | 404 | 387 | 341 | 329 | 330 | 358 | 337 | 668 | 649 | 612 |
| Selling, general and administrative | 1,709 | 1,568 | 1,634 | 1,637 | 1,619 | 1,496 | 1,460 | 1,389 | 1,251 | 1,253 | 1,189 | 1,199 | 1,184 | 1,817 | 1,809 | 1,752 |
| Operating income | 1,479 | 1,488 | 1,350 | 1,618 | 1,347 | 846 | 941 | 904 | 807 | 615 | 522 | 419 | 386 | 1,119 | 1,071 | 566 |
| Other income (expense) | 6 | 49 | 33 | (39) | 92 | 66 | 16 | 79 | 53 | (10) | 17 | (89) | 7 | 16 | 33 | 70 |
| Pretax income | 1,435 | 1,521 | 1,339 | 1,504 | 1,360 | 842 | 919 | 946 | 803 | 544 | 767 | 763 | 732 | 1,384 | 1,310 | 938 |
| Income tax | 132 | 232 | 99 | 250 | 150 | 123 | (152) | 630 | 119 | 82 | 42 | (3) | 68 | (110) | 20 | 8 |
| Net income | 1,303 | 1,289 | 1,240 | 1,254 | 1,210 | 719 | 1,071 | 316 | 684 | 462 | 401 | 549 | 734 | 1,153 | 1,012 | 684 |
| Diluted EPS ($) | 4.57 | 4.43 | 4.19 | 4.18 | 3.94 | 2.30 | 3.37 | 0.97 | 2.10 | 1.40 | 1.20 | 1.62 | 2.13 | 3.27 | 2.85 | 1.94 |
| Diluted shares (millions) | 285 | 291 | 296 | 300 | 307 | 312 | 318 | 325 | 326 | 329 | 335 | 338 | 345 | 353 | 355 | 353 |
Balance sheet
| Millions of dollars | FY2025ended Oct 31, 2025filed Dec 22, 2025 | FY2024ended Oct 31, 2024filed Dec 20, 2024 | FY2023ended Oct 31, 2023filed Dec 20, 2023 | FY2022ended Oct 31, 2022filed Dec 21, 2022 | FY2021ended Oct 31, 2021filed Dec 17, 2021 | FY2020ended Oct 31, 2020filed Dec 18, 2020 | FY2019ended Oct 31, 2019filed Dec 19, 2019 | FY2018ended Oct 31, 2018filed Dec 20, 2018 | FY2017ended Oct 31, 2017filed Dec 21, 2017 | FY2016ended Oct 31, 2016filed Dec 20, 2016 | FY2015ended Oct 31, 2015filed Dec 21, 2015 | FY2014ended Oct 31, 2014filed Dec 22, 2014 | FY2013ended Oct 31, 2013filed Dec 19, 2013 | FY2012ended Oct 31, 2012filed Dec 20, 2012 | FY2011ended Oct 31, 2011filed Dec 16, 2011 | FY2010ended Oct 31, 2010filed Dec 20, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1,789 | 1,329 | 1,590 | 1,053 | 1,484 | 1,441 | 1,382 | 2,247 | 2,678 | 2,289 | 2,003 | 2,218 | 2,675 | 2,351 | 3,527 | 2,649 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 11 | 0 | 0 |
| Total current assets | 4,594 | 3,959 | 4,186 | 3,778 | 3,799 | 3,415 | 3,189 | 3,865 | 4,169 | 3,635 | 3,686 | 5,509 | 4,983 | 4,629 | 5,569 | 6,169 |
| Total assets | 12,727 | 11,846 | 10,763 | 10,532 | 10,705 | 9,627 | 9,452 | 8,558 | 8,426 | 7,794 | 7,479 | 10,815 | 10,686 | 10,536 | 9,057 | 9,696 |
| Total current liabilities | 2,347 | 1,895 | 1,603 | 1,861 | 1,708 | 1,467 | 2,080 | 1,160 | 1,263 | 945 | 976 | 1,692 | 1,602 | 1,893 | 1,837 | 3,083 |
| Long-term debt | 3,050 | 3,345 | 2,735 | 2,733 | 2,729 | 2,284 | 1,791 | 1,799 | 1,801 | 1,904 | 1,655 | 1,663 | 2,699 | 2,112 | 1,932 | 2,190 |
| Total liabilities | 5,986 | 5,948 | 4,918 | 5,227 | 5,316 | 4,754 | 4,704 | 3,961 | 3,591 | 3,548 | 3,309 | 5,511 | 5,397 | 5,351 | 4,741 | 6,460 |
| Stockholders’ equity | 6,741 | 5,898 | 5,845 | 5,305 | 5,389 | 4,873 | 4,748 | 4,593 | 4,831 | 4,243 | 4,167 | 5,301 | 5,286 | 5,182 | 4,308 | 3,228 |
| Shares outstanding (millions) | 283 | 286 | 293 | 296 | 302 | 307 | 310 | 319 | 323 | 322 | 332 | 335 | 332 | 348 | 348 | 348 |
Cash flow statement
| Millions of dollars | FY2025ended Oct 31, 2025filed Dec 22, 2025 | FY2024ended Oct 31, 2024filed Dec 20, 2024 | FY2023ended Oct 31, 2023filed Dec 20, 2023 | FY2022ended Oct 31, 2022filed Dec 21, 2022 | FY2021ended Oct 31, 2021filed Dec 17, 2021 | FY2020ended Oct 31, 2020filed Dec 18, 2020 | FY2019ended Oct 31, 2019filed Dec 19, 2019 | FY2018ended Oct 31, 2018filed Dec 20, 2018 | FY2017ended Oct 31, 2017filed Dec 21, 2017 | FY2016ended Oct 31, 2016filed Dec 20, 2016 | FY2015ended Oct 31, 2015filed Dec 21, 2015 | FY2014ended Oct 31, 2014filed Dec 22, 2014 | FY2013ended Oct 31, 2013filed Dec 19, 2013 | FY2012ended Oct 31, 2012filed Dec 20, 2012 | FY2011ended Oct 31, 2011filed Dec 16, 2011 | FY2010ended Oct 31, 2010filed Dec 20, 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,559 | 1,751 | 1,772 | 1,312 | 1,485 | 921 | 1,021 | 1,087 | 889 | 793 | 512 | 731 | 1,152 | 1,228 | 1,260 | 718 |
| Capital expenditures | 407 | 378 | 298 | 291 | 188 | 119 | 155 | 177 | 176 | 139 | 98 | 205 | 195 | 194 | 188 | 121 |
| Free cash flow (CFO − capex) | 1,152 | 1,373 | 1,474 | 1,021 | 1,297 | 802 | 866 | 910 | 713 | 654 | 414 | 526 | 957 | 1,034 | 1,072 | 597 |
| Depreciation and amortization | 288 | 257 | 271 | 317 | 321 | 308 | 238 | 210 | 212 | 246 | 253 | 384 | 372 | 301 | 253 | 202 |
| Share repurchases | 425 | 1,150 | 575 | 1,139 | 788 | 469 | 723 | 422 | 194 | 434 | 267 | 200 | 900 | 172 | 497 | 411 |
| Dividends paid | 282 | 274 | 265 | 250 | 236 | 222 | 206 | 191 | 170 | 150 | 133 | 176 | 156 | 104 | 0 | 0 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Boehnlein Glenn S | Director | award | 817 | $146.85 | $120K | 817 | Sep 10, 2026 |
| Sep 4, 2026 | Dolsten Mikael | Director | open-market sale | 634 | $151.38 | $96K | 4,924 | Sep 9, 2026 |
| Jun 26, 2026 | Kirkwood Jonah Prevost | Senior Vice President | tax withholding | 30 | $136.01 | $4K | 14,108 | Jun 29, 2026 |
| Jun 3, 2026 | Mcdonnell Padraig | President and CEO, Director | tax withholding | 418 | $137.40 | $57K | 65,842 | Jun 5, 2026 |
| May 29, 2026 | Dolsten Mikael | Director | open-market sale | 1,600 | $135.42 | $217K | 5,548 | Jun 2, 2026 |
| May 19, 2026 | Buckner Michael Steven | Senior Vice President | award | 8,872 | $0.00 | — | 8,887 | May 21, 2026 |
| May 8, 2026 | May Simon | Senior Vice President | tax withholding | 368 | $115.62 | $43K | 14,015 | May 12, 2026 |
| Mar 31, 2026 | Henson Meghan | Senior Vice President | tax withholding | 153 | $113.98 | $17K | 6,890 | Apr 2, 2026 |
| Mar 19, 2026 | Rataj Sue H. | Director | award | 2,158 | $111.75 | $241K | 23,617 | Mar 23, 2026 |
| Mar 19, 2026 | Brawley Otis W | Director | award | 2,158 | $111.75 | $241K | 12,986 | Mar 23, 2026 |
| Mar 19, 2026 | Brawley Otis W | Director | award | 888 | $111.75 | $99K | 13,874 | Mar 23, 2026 |
| Mar 19, 2026 | Scangos George A | Director | award | 1,057 | $111.75 | $118K | 23,857 | Mar 23, 2026 |
| Mar 19, 2026 | Scangos George A | Director | award | 2,158 | $111.75 | $241K | 22,800 | Mar 23, 2026 |
| Mar 19, 2026 | Soriot Pascal | Director | tax withholding | 648 | $111.75 | $72K | 2,683 | Mar 23, 2026 |
| Mar 19, 2026 | Soriot Pascal | Director | award | 2,158 | $111.75 | $241K | 3,331 | Mar 23, 2026 |
| Mar 19, 2026 | Wilson Dow R | Director | award | 2,158 | $111.75 | $241K | 20,369 | Mar 23, 2026 |
| Mar 19, 2026 | Podolsky Daniel K | Director | award | 2,158 | $111.75 | $241K | 38,180 | Mar 23, 2026 |
| Mar 19, 2026 | Koh Boon Hwee | Director | award | 2,158 | $111.75 | $241K | 63,832 | Mar 23, 2026 |
| Mar 19, 2026 | Koh Boon Hwee | Director | tax withholding | 648 | $111.75 | $72K | 63,184 | Mar 23, 2026 |
| Mar 19, 2026 | Dolsten Mikael | Director | award | 2,158 | $111.75 | $241K | 7,138 | Mar 23, 2026 |
| Mar 19, 2026 | Brown Judy L | Director | award | 2,158 | $111.75 | $241K | 3,835 | Mar 23, 2026 |
| Mar 19, 2026 | Anand Mala | Director | award | 2,158 | $111.75 | $241K | 16,705 | Mar 23, 2026 |
| Feb 27, 2026 | Riemann Angelica | Senior Vice President | tax withholding | 89 | $121.38 | $11K | 26,535 | Mar 3, 2026 |
| Feb 27, 2026 | Mcdonnell Padraig | President and CEO, Director | tax withholding | 279 | $121.38 | $34K | 66,260 | Mar 3, 2026 |
| Feb 27, 2026 | Kirkwood Jonah Prevost | Senior Vice President | tax withholding | 124 | $121.38 | $15K | 14,138 | Mar 3, 2026 |
Full insider history for Agilent Technologies Inc., or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held A in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded A by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Baron Capital Group | Ron Baron | Q2 2026 | $5M | 36,589 | 0.01% | held |
Sources
Fiscal year ends in month 10; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- AGILENT TECHNOLOGIES, INC., CIK 1090872 on EDGAR
- Extract generated
- October 6, 2026
- Withheld
- 1 line-years whose four quarters do not sum to the filed year: pretax income FY2017
- Repaired
- 2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2010, other income FY2013
XBRL concepts behind each line
Income statement
RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNetCostOfGoodsAndServicesSold, CostOfRevenueResearchAndDevelopmentExpenseSellingGeneralAndAdministrativeExpenseOperatingIncomeLossOtherNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest, IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsIncomeTaxExpenseBenefitNetIncomeLoss, ProfitLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueShortTermInvestmentsAssetsCurrentAssetsLiabilitiesCurrentLongTermDebt, LongTermDebtNoncurrentLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesPaymentsToAcquirePropertyPlantAndEquipmentDepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfDividendsCommonStockThe data
The statements on this page as files, generated October 6, 2026.
- JSON file
/data/financials/A.json